RxSight, Inc. Operating Cash Flow
RxSight, Inc. (RXST) reported Operating Cash Flow of -$20.43 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- RxSight, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$9.54M.
- RxSight, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$10.89M.
- RxSight, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$1.12M.
- RxSight, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$1.19M, a 282.62% decline year-over-year.
- RxSight, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$15.51M.
- RxSight, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$16.95M.
- RxSight, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$41.59M.
- RxSight, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$58.85M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$9.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$20.43M 10-Q · filed 2026-08-05 | -$21.55M derived: sum of 3 quarters · filed 2026-08-05 | -$22.73M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$10.89M 10-Q · filed 2026-05-06 | -$12.01M derived: sum of 2 quarters · filed 2026-05-06 | -$13.19M derived: sum of 3 quarters · filed 2026-05-06 | -$17.57M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$1.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$2.30M derived: sum of 2 quarters · filed 2026-02-25 | -$6.68M derived: sum of 3 quarters · filed 2026-08-05 | -$15.51M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$5.56M derived: sum of 2 quarters · filed 2026-08-05 | -$14.39M 10-Q · filed 2025-11-05 | -$18.66M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$4.38M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$13.21M 10-Q · filed 2026-08-05 | -$17.47M derived: sum of 3 quarters · filed 2026-08-05 | -$16.82M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$8.83M 10-Q · filed 2026-05-06 | -$13.09M derived: sum of 2 quarters · filed 2026-05-06 | -$12.44M derived: sum of 3 quarters · filed 2026-05-06 | -$16.47M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | -$4.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$3.61M derived: sum of 2 quarters · filed 2026-02-25 | -$7.64M derived: sum of 3 quarters · filed 2026-02-25 | -$16.95M 10-K · filed 2026-02-25 |
| 2024-09-30 | $650.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$3.38M derived: sum of 2 quarters · filed 2025-11-05 | -$12.69M 10-Q · filed 2025-11-05 | -$20.99M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$4.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$13.34M 10-Q · filed 2025-08-07 | -$21.64M derived: sum of 3 quarters · filed 2026-02-25 | -$29.62M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$9.31M 10-Q · filed 2025-05-07 | -$17.61M derived: sum of 2 quarters · filed 2026-02-25 | -$25.59M derived: sum of 3 quarters · filed 2026-02-25 | -$33.14M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$16.28M derived: sum of 2 quarters · filed 2026-02-25 | -$23.83M derived: sum of 3 quarters · filed 2026-02-25 | -$41.59M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$7.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$15.53M derived: sum of 2 quarters · filed 2024-11-07 | -$33.29M 10-Q · filed 2024-11-07 | -$47.15M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | -$7.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | -$25.31M 10-Q · filed 2024-08-05 | -$39.16M derived: sum of 3 quarters · filed 2025-02-25 | -$54.35M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | -$17.76M 10-Q · filed 2024-05-06 | -$31.62M derived: sum of 2 quarters · filed 2025-02-25 | -$46.81M derived: sum of 3 quarters · filed 2025-02-25 | -$61.63M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | -$13.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | -$29.04M derived: sum of 2 quarters · filed 2025-02-25 | -$43.87M derived: sum of 3 quarters · filed 2025-02-25 | -$58.85M 10-K · filed 2025-02-25 |
| 2022-09-30 | -$15.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$30.01M derived: sum of 2 quarters · filed 2023-11-09 | -$45.00M 10-Q · filed 2023-11-09 | -$53.72M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$14.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | -$29.81M 10-Q · filed 2023-08-07 | -$38.53M derived: sum of 3 quarters · filed 2023-08-07 | -$52.28M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | -$14.98M 10-Q · filed 2023-05-09 | -$23.71M derived: sum of 2 quarters · filed 2023-05-09 | -$37.46M derived: sum of 3 quarters · filed 2023-05-09 | -$49.44M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | -$8.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$22.48M derived: sum of 2 quarters · filed 2023-03-06 | -$34.46M derived: sum of 3 quarters · filed 2023-03-06 | -$44.71M 10-K · filed 2023-03-06 |
| 2021-09-30 | -$13.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | -$25.73M derived: sum of 2 quarters · filed 2022-11-07 | -$35.99M 10-Q · filed 2022-11-07 | -$44.21M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | -$11.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$22.23M 10-Q · filed 2022-08-08 | -$30.46M derived: sum of 3 quarters · filed 2022-08-08 | -$37.41M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$10.25M 10-Q · filed 2022-05-05 | -$18.48M derived: sum of 2 quarters · filed 2022-05-05 | -$25.43M derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | -$8.23M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | -$15.18M derived: sum of 2 quarters · filed 2022-03-08 | -$35.20M 10-K · filed 2022-03-08 | |
| 2020-09-30 | -$6.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$26.98M 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | -$20.03M 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |